Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
FibroBiologics Inc. (FBLG) had Return on Tangible Equity of -211.32% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.97M |
|
-- |
|
-- |
|
$4.53M |
|
$-4.53M |
|
$-0.43M |
|
$-4.97M |
|
$-4.97M |
|
$-4.97M |
|
$-4.97M |
|
$-4.97M |
|
$-4.97M |
|
$-4.53M |
|
$-4.37M |
|
36.67M |
|
36.67M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$9.33M |
|
$0.81M |
|
$2.10M |
|
$11.43M |
|
$8.21M |
|
-- |
|
$0.86M |
|
$9.08M |
|
$2.35M |
|
$2.35M |
|
$2.35M |
|
37.73M |
|
| Cash Flow Statement Financials | |
$-5.28M |
|
$-0.04M |
|
-- |
|
$13.98M |
|
$8.67M |
|
$-5.32M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.14 |
|
-- |
|
-- |
|
-- |
|
2.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-211.32% |
|
|
Return on Tangible Equity |
-211.32% |
-43.46% |
|
-211.32% |
|
$0.06 |
|
$-0.14 |
|
$-0.14 |
|